Airway effects of marijuana, cocaine, and other inhaled illicit agents

Current Opinion in Pulmonary Medicine

Volumn 7, Issue 2, 2001, Pages 43-61

  Tashkin, Donald P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYL NITRITE; BUTYL NITRITE; CANNABIS; COCAINE; DIAMORPHINE; METHAMPHETAMINE; PHENCYCLIDINE;

ASTHMA; DISEASE EXACERBATION; HUMAN; LUNG ALVEOLUS MACROPHAGE; LUNG CANCER; LUNG INFECTION; LUNG INJURY; MICROVASCULATURE; RESPIRATORY TRACT DISEASE; REVIEW; TOBACCO;

EID: 0035089020     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200103000-00001     Document Type: Review

References (139)

1. Marijuana and lung function
2. Single-dose effect of marihuana smoke
3. 9-tetrahydrocannabinol in healthy young men
4. 9-tetrahydrocannabinol on specific airway conductance in subjects with asthma
5. Effects of smoked marijuana in experimentally induced asthma
6. 1-trans-tetrahydrocannabinol in reversible airway obstruction
7. 9-tetrahydrocannabinol on airway mechanics in normal and subjects with asthma
8. Subacute effects of heavy marihuana smoking on pulmonary function in healthy men
9. 9-tetrahydrocannabinol in healthy and subjects with asthma
10. 1-tetrahydrocannabinol administered by aerosol to asthmatic patients
11. 1-tetrahydrocannabinol
12. 1-tetrahydrocannabinol on cyclic AMP levels in W1-38 fibroblasts
13. Effects of β-adrenergic blockade and muscarinic stimulation on cannabis bronchodilation
14. 9-transtetrahydrocannabinol in mongrel dogs
15. Inhibition by cannabinoid receptor agonists of acetylcholine release from guinea-pig myenteric plexus
16. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
17. Structure of a cannabinoid receptor and functional expression of the cloned cDNA
18. Molecular characterization of a peripheral receptor for cannabinoids
19. Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs
20. Bidirectional control of airway responsiveness by endogenous cannabinoids
21. Natural and synthetic endocannabinoids and their structure-activity relationships
22. Respiratory symptoms and lung function in habitual, heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers
23. Respiratory effects of nontobacco cigarettes
24. The respiratory effects of cannabis dependence in young adults
25. Respiratory effects of nontobacco cigarettes: A longitudinal study in general population
26. 1 with age: A longitudinal study
27. The comparative response of the lung to marihuana or tobacco smoke inhalation
28. Health care use by frequent marijuana smokers who do not smoke tobacco
29. Pneumothorax in polysubstance abusing marijuana and tobacco smokers: 3 Cases
30. Pneumomediastinum in heroin and marijuana users
31. Pneumomediastinum resulting from performing Valsalva maneuvers during marijuana smoking
32. Large lung bullae in marijuana smokers
33. Marijuana use and mortality
34. Visual and pathologic evidence of injury to the airway of young marijuana smokers
35. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana or tobacco
36. Changes in bronchial epithelium in relation to cigarette smoking and its relation to lung cancer
37. Pulmonary hazards of smoking marijuana as compared with tobacco
38. Effects of varying marijuana smoking profile on deposition of tar and absorption of CO and delta-9-THC
39. Similar molecular alterations in bronchial epithellium are observed in habitual smokers of marijuana, cocaine or tobacco
40. Oxidative stress produced by cannabinoids in marijuana smoke
41. Differential examination of bronchoalveolar lavage cells in tobacco cigarette and marijuana smokers
42. Morphological alterations of alveolar macrophages from marijuana smokers
43. Respiratory burst and microbicidal characteristics of pulmonary alveolar macrophages recovered from smokers of marijuana alone, smokers of tobacco alone, smokers of marijuana and tobacco and nonsmokers
44. Habitual smoking of marijuana and cocaine impairs alveolar macrophage function and cytokine production
45. Marijuana smoking, pulmonary function and lung macrophage oxidant release
46. Nitric oxide: A mediator of alveolar macrophage antimicrobial activity compromised in cocaine and marijuana smokers
47. On the carcinogenicity of marijuana smoke
48. Fractionation and capillary gas chromatographic mass spectrometric characterization of the neutral components in marijuana and tobacco smoke concentrates
49. Gas chromatography/mass spectrometric and nuclear magnetic resonance spectrometric studies of carcinogenic polynuclear aromatic hydrocarbons in tobacco and marijuana smoke condensates
50. Preferential formation of benz[α]pyrene adducts at lung cancer mutational hotspots in p53
51. 9-tetrahydrocannabinol
52. Mutagenic activity of marihuana smoke condensates
53. Mutagenicity of marijuana and Transkei tobacco smoke condensates in the Salmonella/microsome assay
54. Toxic effects of marihuana tar on mouse skin
55. Cytological and cytochemical studies of the effects of fresh marihuana cigarette smoke on growth and DNA memtabolism of a nimal and human lung cultures
56. Marijuana, immunity and infection
57. Cannabinoid-receptor expression in human leukocytes
58. 9-tetrahydrocannabinol injection
59. 9-tetrahydrocannabinol inhibits antitumor immune-surveillance by a CB2 receptor-mediated, cytokine-dependent pathway
60. Delta-9-tetrahydrocannabinol suppresses antigen-induced proliferation and interferon-γ production by human T cells
61. Marijuana as a potential respiratory tract carcinogen: A retrospective analysis of a community hospital population
62. Advanced malignancy in the young marijuana smoker
63. Possible role of marijuana smoking as a carcinogen in the development of lung cancer at a young age
64. Marijuana and head and neck cancer
65. Lung and aero-digestive cancers in young marijuana smokers
66. Marijuana use and mortality
67. Marijuana use and increased risk of squamous cell carcinoma of the head and neck
68. Federal foolishness and marijuana
69. Tracheobronchial changes in habitual, heavy smokers of marijuana with and without tobacco
70. Pulmonary aspergillosis in the acquired immunodeficiency syndrome
71. Pulmonary aspergillosis, inhalation of contaminated marijuana smoke, chronic granulomatous disease
72. Fatal aspergillosis associated with smoking contaminated marijuana in a marrow transplant recipient
73. Possible risk of invasive pulmonary aspergillosis with marijuana use during chemotherapy for small cell lung cancer
74. Successfully treated invasive pulmonary aspergillosis associated with smoking marijuana in a renal transplant recipient
75. Marijuana smoking and fungal sensitization
76. Contamination of marihuana cigarettes with pathogenic bacteria-possible source of infection in cancer patients
77. Necrotizing pulmonary granulomata in a marijuana smoker
78. Risk factor analysis among men referred for possible acquired immune deficiency syndrome
79. The Sydney AIDS project: Development of acquired immunodeficiency syndrome in a goup of HIV seropositive homosexual men
80. Drug smoking, Pneumocystis carinii pneumonia, and immunosuppresion increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive infection drug users
81. Pulmonary effects of the cocaine pyrolysis rpduct, methylecgonidine, in guinea pigs
82. Cocaine abuse
83. The pulmonary complications of crack cocaine: A comprehensive revue
84. Association of asthma and freebase cocaine
85. Cocaine-associated asthma
86. Crack abuse and asthma: A fatal combination
87. Pneumomediastinum resulting from performing valsalva manaeuver during marijuana smoking
88. Pneumomediastinum and pneumothorax after inhaling alkaloidal cocaine
89. Spontaneous pneumomediastinum as a consequence of cocaine use
90. Penumomediastinum and cervical emphysema from the inhalation of freebased cocaine: Report of three cases
91. Barotrauma related to inhalational drug abuse
92. Spontaneous pneumomediastinum in an 18-year-old black Sudanese high school student
93. Nonfatal pulmonary edema after free-base cocaine smoking
94. Diffuse alveolar hemorrhage temporally related to cocaine smoking
95. Crack lung pulmonary disease caused by cocaine abuse
96. Cocaine induced eosinophilic lung diseases
97. Interstitial pneumonitis associated with crack cocaine abuse
98. Free-base cocaine use associated with bronchiolitis obliterans organizing pneumonia
99. Crack lung: An acute pulmonary syndrome with a spectrum of clinical and histopathological findings
100. Prevalence of cocaine use and its impact on asthma exacerbation in an urban population
101. Pulmonary status of habitual cocaine smokers
102. Pulmonary dysfunction in freebase cocaine users
103. Respiratory effects of cocaine freebasing among habitual users of marijuana with or without tobacco
104. Lung sound abnormalities in cocaine freebasers
105. Cocaine smoking
106. Acute effects of inhaled and intravenous cocaine on airway dynamics
107. Pulmonary function in male freebase cocaine smokers
108. Pulmonary dysfunction in cocaine smokers
109. Pulmonary function in heavy users of freebase cocaine
110. Acute effects of intravenous cocaine on pulmonary artery pressure and cardiac index in habitual crack users
111. Membrane diffusing capacity and capillary blood volume in habitual crack smokers
112. Increased lung permeability following long-term use of free-base cocaine (crack)
113. Effects of crack cocaine on pulmonary alveolar permeability
114. NIDA Conference Report: Cardiopulmonary complications of crack cocaine use-clinical manifestations and pathophysiology
115. Impact of habitual cocaine smoking on the physiological response to maximum exercise
116. Pulmonary artery medial hypertrophy in cocaine users without foreign particle microembolization
117. Pulmonary histopathology in cocaine abusers
118. Cocaine-induced injury to the pulmonary microcirculation
119. Cocaine increases the endothelial release of immunoreactive endothelin andits concentrations in human plasma and urine
120. Cocaine-stimulated endothelin-1 release is decreased by angiotensin-converting enzyme inhibitors in cultured endothelial cells
121. Blackened bronchoalveolar lavage fluid in crack smokers
122. Pulmonary complicaations from alveolar accumulation of carbonaceious material in a cocaine smoker
123. Acute and chronic effects of cocaine on the immune system and the possible link to AIDS
124. Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures: Involvement of transforming growth factor-beta
125. Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine
126. Cocaine use and HIV infection in intravenous drug users in San Francisco
127. Heterosexual transmission of HIV-1 associated with the use of smokable freebase cocaine (crack)
128. Acute activation of circulating PMNs following in vivo administration of cocaine: A potential etiology for pulmonary injury
129. Functional activation of human neutrophils by recombinant monoycte-derived neutrophil chemotactic factor/IL-8
130. Pulmonary manifestations of inhaled street drugs
131. Heroin inhalation and asthma
132. Bronchospasm and heroin inhalation
133. Airway obstruction and heroin inhalation
134. Acute eosinophilic pneumonia in a heroin smokers
135. Crystal methamphetamine-induced acute pulmonary edema: A case report
136. Pulmonary hypertension associated with long-term inhalation of crank methamphetamine
137. Ecstasy induced retropharyngeal emphysema